| Environmental pollution, apolipoprotein A-1 autoantibodies and cardiovascular risk : evidence from a geospatial cross-sectional study | Atherosclerosis plus |  | | 2026 | 9 | 10 |
|
| Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromes | European journal of clinical investigation | | | 2025 | 7 | 34 |
|
| Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes | Atherosclerosis plus | | | 2024 | 14 | 25 |
|
| Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndrome | European journal of preventive cardiology | | | 2024 | 66 | 160 |
|
| Case report : desmoplakin cardiomyopathy presenting as an inflammatory cardiomyopathy with repeated sudden cardiac arrests | European heart journal. Case reports | | | 2024 | 20 | 149 |
|
| Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study (Swiss Cardiovascular SARS-CoV-2 Consortium) | Frontiers in cardiovascular medicine | | | 2023 | 99 | 29 |
|
| Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes | European heart journal. Acute cardiovascular care | | | 2023 | 61 | 244 |
|
| Utilité clinique des genome boards pour les maladies génétiques complexes | Revue médicale suisse | | | 2023 | 198 | 194 |
|
| Utilisation de l’acétazolamide dans l’insuffisance cardiaque aiguë | Revue médicale suisse | | | 2023 | 94 | 165 |
|
| Recommandations européennes 2021 pour la prévention cardiovasculaire : nouveautés | Revue médicale suisse |  | | 2022 | 294 | 2 |
|
| Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study | Swiss medical weekly | | | 2022 | 79 | 72 |
|
| Effectiveness, adherence, and safety of evolocumab in a swiss multicenter prospective observational study | Advances in therapy | | | 2022 | 227 | 299 |
|
| The 'ten commandments' for the 2021 ESC Guidelines on CVD prevention | European heart journal | | | 2022 | 128 | 394 |
|
| European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology | European journal of preventive cardiology | | | 2022 | 263 | 0 |
|
| Risks and benefits of urinary catheterisation during inpatient diuretic therapy for acute heart failure: a retrospective, non-inferiority, cohort study | BMJ open | | | 2022 | 137 | 100 |
|
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice | European journal of preventive cardiology | | | 2022 | 433 | 5,584 |
|
| Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS)-A phase II, randomized, double-blind, multi-center, placebo-controlled trial | The American heart journal | | | 2022 | 167 | 0 |
|
| Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure | Journal of clinical medicine | | | 2021 | 235 | 123 |
|
| Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease | Open Heart | | | 2021 | 255 | 214 |
|
| Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events | Atherosclerosis | | | 2021 | 230 | 98 |
|
| Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | | | 2021 | 215 | 252 |
|
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice | European heart journal | | | 2021 | 660 | 9 |
|
| The value of cohort studies in cardiovascular medicine | |  | | 2021 | 414 | 0 |
|
| CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients | Atherosclerosis | | | 2021 | 173 | 68 |
|
| Changement climatique et enjeux cliniques | Revue médicale suisse | | | 2021 | 232 | 4 |
|
| Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode | Schweizerische medizinische Wochenschrift | | | 2021 | 295 | 148 |
|
| Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines | European journal of preventive cardiology | | | 2021 | 167 | 0 |
|
| Optimal timing of invasive coronary angiography following NSTEMI | Journal of interventional cardiology | | | 2020 | 241 | 224 |
|
| Prognosis of patients eligible for dapagliflozin in acute heart failure | European journal of clinical investigation | | | 2020 | 231 | 0 |
|
| Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort | International journal of cardiology | | | 2020 | 225 | 0 |
|
| Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors | International journal of cardiology | | | 2020 | 168 | 0 |
|
| Eligibility for sacubitril-valsartan in patients with acute decompensated heart failure | ESC heart failure | | | 2020 | 282 | 151 |
|
| La myocardite en 2020 | Revue médicale suisse | | | 2020 | 473 | 830 |
|
| Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention | PloS one | | | 2019 | 63 | 139 |
|
| Prognostic value of the echocardiographic probability of pulmonary hypertension in patients with acute decompensated heart failure | Journal of clinical medicine | | | 2019 | 406 | 107 |
|
| Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart Disease | International Journal of Molecular Sciences | | | 2018 | 618 | 248 |
|
| Usefulness of P-wave signal averaging to predict atrial fibrillation recurrences after electrical cardioversion | Annals of noninvasive electrocardiology | | | 2014 | 578 | 0 |
|
| A Palpable Source of Stroke | Circulation | | | 2011 | 79 | 0 |
|
